Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase 3 2Phase 1 1

Status

Unknown 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Myasthenia Gravis 2Strabismus 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Emergence Delirium 1Autoimmune Diseases 1

Interventions

Dexamethasone 56Metformin 50Cyclophosphamide 47Saline Solution 39Cytarabine 37Cisplatin 36Zoledronic Acid 34Letrozole 34Carboplatin 33Sodium Chloride 32Bupivacaine 31Docetaxel 30Bevacizumab 30Vincristine 29Methotrexate 29Fluorouracil 28Propofol 27Capecitabine 27Fentanyl 26Doxorubicin 26Rituximab 25Drug Therapy 25Dexmedetomidine 25Prednisone 23Paclitaxel 23Oxaliplatin 21Morphine 21Gemcitabine 21Radiotherapy 19Prednisolone 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Pyridostigmine Bromide × Clear all
NCT06035757 2026-03-03

The Occurrence of Emergence Agitation in Pediatric Strabismus Surgery

Konkuk University Medical Center

Phase 4 Recruiting
76 enrolled
LymphoidOther hematologic neoplasm

Emergence Delirium, Strabismus, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06723548 2024-12-09

Telitacicept and Low-dose Steroids in Refractory Myasthenia Gravis

First Affiliated Hospital of Wenzhou Medical University

Phase 4 Not yet recruiting
30 enrolled

Autoimmune Diseases, Myasthenia Gravis

NCT03510546 2018-04-27

Effect of Pyridostigmine (Mestinon) on Muscle Strength in Myasthenia Gravis

University of Aarhus

Phase 4 Unknown
44 enrolled

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡